相似文献
1
A ligand-binding pocket in the dengue virus envelope glycoprotein.
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6986-91. doi: 10.1073/pnas.0832193100. Epub 2003 May 20.
2
Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion.
J Virol. 2009 May;83(9):4338-44. doi: 10.1128/JVI.02574-08. Epub 2009 Feb 25.
3
Dengue virus envelope glycoprotein structure: new insight into its interactions during viral entry.
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6899-901. doi: 10.1073/pnas.1332695100. Epub 2003 Jun 2.
4
Structure of the dengue virus envelope protein after membrane fusion.
Nature. 2004 Jan 22;427(6972):313-9. doi: 10.1038/nature02165.
5
Picture story. Does Dengue virus fuse using beta-barrels?
Nat Struct Biol. 2002 Apr;9(4):244. doi: 10.1038/nsb0402-244.
6
Prediction of the post-translational modification sites on dengue virus E protein and deciphering their role in pathogenesis.
Int J Bioinform Res Appl. 2010;6(5):508-21. doi: 10.1504/IJBRA.2010.037989.
7
The flavivirus precursor membrane-envelope protein complex: structure and maturation.
Science. 2008 Mar 28;319(5871):1830-4. doi: 10.1126/science.1153263.
8
Atomic-level functional model of dengue virus Envelope protein infectivity.
Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18662-7. doi: 10.1073/pnas.1310962110. Epub 2013 Oct 24.
9
Structure of the immature dengue virus at low pH primes proteolytic maturation.
Science. 2008 Mar 28;319(5871):1834-7. doi: 10.1126/science.1153264.
10
Small-molecule inhibitors of dengue-virus entry.
PLoS Pathog. 2012;8(4):e1002627. doi: 10.1371/journal.ppat.1002627. Epub 2012 Apr 5.
引用本文的文献
1
Irreversible furin cleavage site exposure renders immature tick-borne flaviviruses fully infectious.
Nat Commun. 2025 Aug 12;16(1):7491. doi: 10.1038/s41467-025-62750-6.
2
Production of Envelope Protein-Based Virus-like Particles of DENV‑2 in and Investigation of Their Binding Interactions with Gallic Acid Derivatives of Glucose as Potential Drug Candidates.
ACS Omega. 2025 Jul 21;10(30):33090-33107. doi: 10.1021/acsomega.5c02548. eCollection 2025 Aug 5.
3
Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study.
Sci Rep. 2025 Jul 30;15(1):27878. doi: 10.1038/s41598-025-06974-y.
4
Atomic-resolution structure of a chimeric Powassan tick-borne flavivirus.
Sci Adv. 2025 Jul 11;11(28):eadw7700. doi: 10.1126/sciadv.adw7700. Epub 2025 Jul 9.
5
Computational insights into flavonoids inhibition of dengue virus envelope protein: ADMET profiling, molecular docking, dynamics, PCA, and end-state free energy calculations.
PLoS One. 2025 Jul 9;20(7):e0327862. doi: 10.1371/journal.pone.0327862. eCollection 2025.
6
A Scoping Review of Preclinical Research on Monoclonal Antibody Development for Prophylaxis and Treatment of West Nile Virus Infections.
Viruses. 2025 Jun 12;17(6):845. doi: 10.3390/v17060845.
7
A two-component cocktail of engineered DIII nanoparticles elicits broadly neutralizing antibody responses against dengue virus in mice.
iScience. 2025 Apr 29;28(6):112534. doi: 10.1016/j.isci.2025.112534. eCollection 2025 Jun 20.
8
From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity.
Vaccines (Basel). 2025 Apr 24;13(5):449. doi: 10.3390/vaccines13050449.
9
Exploiting host kinases to combat dengue virus infection and disease.
Antiviral Res. 2025 May 8;241:106172. doi: 10.1016/j.antiviral.2025.106172.
10
Zika virus M protein latches and locks the E protein from transitioning to an immature state after prM cleavage.
Npj Viruses. 2023 Nov 6;1(1):4. doi: 10.1038/s44298-023-00004-2.
本文引用的文献
1
[27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods.
Methods Enzymol. 1997;276:472-494. doi: 10.1016/S0076-6879(97)76073-7.
2
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
3
Raster3D: photorealistic molecular graphics.
Methods Enzymol. 1997;277:505-24. doi: 10.1016/s0076-6879(97)77028-9.
4
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.
Cell. 2002 Mar 8;108(5):717-25. doi: 10.1016/s0092-8674(02)00660-8.
5
Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century.
Trends Microbiol. 2002 Feb;10(2):100-3. doi: 10.1016/s0966-842x(01)02288-0.
6
Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
J Virol. 2002 Feb;76(4):1932-43. doi: 10.1128/jvi.76.4.1932-1943.2002.
7
Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay.
Clin Diagn Lab Immunol. 2001 Nov;8(6):1150-5. doi: 10.1128/CDLI.8.6.1150-1155.2001.
8
Implementation of molecular replacement in AMoRe.
Acta Crystallogr D Biol Crystallogr. 2001 Oct;57(Pt 10):1367-72. doi: 10.1107/s0907444901012422. Epub 2001 Sep 21.
9
The machinery for flavivirus fusion with host cell membranes.
Curr Opin Microbiol. 2001 Aug;4(4):450-5. doi: 10.1016/s1369-5274(00)00234-4.
10
Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus.
Mol Cell. 2001 Mar;7(3):593-602. doi: 10.1016/s1097-2765(01)00206-4.
Zotero 插件